Thomson Reuters Corp. Stock Rises Friday, Outperforms Market
Dow Jones2026/10/09 20:36This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Thomson Reuters Corp. TRI rallied 1.97% to C$147.30 Friday, in what proved to be an all-around favorable trading session for the Canadian market, with the S&P/TSX Composite Index rising 1.48% to 35,664.62. Thomson Reuters Corp. closed 36.0% below its 52-week high of C$230.00, which the company reached on October 24th. Trading volume of 484,542 shares remained below its 50-day average volume of 669,951. Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires October 09, 2026 16:36 ET (20:36 GMT)
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Thomson Reuters Corp. TRI rallied 1.97% to C$147.30 Friday, in what proved to be an all-around favorable trading session for the Canadian market, with the S&P/TSX Composite Index rising 1.48% to 35,664.62.
Thomson Reuters Corp. closed 36.0% below its 52-week high of C$230.00, which the company reached on October 24th.
Trading volume of 484,542 shares remained below its 50-day average volume of 669,951.
Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 09, 2026 16:36 ET (20:36 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Medifast updates financial calendar
Zurn Elkay Water Solutions publishes update to financial calendar
MannKind CEO to Join Chronic Respiratory Disease Panel at Chardan Healthcare Conference